Deborah McCloskey

568 total citations
6 papers, 292 citations indexed

About

Deborah McCloskey is a scholar working on Pathology and Forensic Medicine, Dermatology and Immunology. According to data from OpenAlex, Deborah McCloskey has authored 6 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 2 papers in Dermatology and 2 papers in Immunology. Recurrent topics in Deborah McCloskey's work include Systemic Sclerosis and Related Diseases (4 papers), Dermatologic Treatments and Research (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Deborah McCloskey is often cited by papers focused on Systemic Sclerosis and Related Diseases (4 papers), Dermatologic Treatments and Research (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). Deborah McCloskey collaborates with scholars based in United States. Deborah McCloskey's co-authors include James R. Seibold, Robert A. Wise, William P. Dole, Fred Wigley, Ann Impens, Kristine Phillips, Vivien Hsu, Elena Schiopu, Jennifer Rothman and D. Riley and has published in prestigious journals such as BMC Medicine, Current Opinion in Rheumatology and The Journal of Rheumatology.

In The Last Decade

Deborah McCloskey

6 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah McCloskey United States	6	236	122	101	62	37	6	292
Josephine Vila Spain	8	125 0.5×	65 0.5×	81 0.8×	98 1.6×	23 0.6×	17	292
Russell Steele Canada	6	193 0.8×	55 0.5×	61 0.6×	72 1.2×	52 1.4×	6	260
Geneviève Gyger Canada	9	235 1.0×	114 0.9×	74 0.7×	48 0.8×	40 1.1×	16	307
T.A. Luger Germany	9	160 0.7×	197 1.6×	107 1.1×	11 0.2×	60 1.6×	14	347
Filiz Cebeci Türkiye	8	49 0.2×	57 0.5×	29 0.3×	23 0.4×	56 1.5×	27	197
Caitlin M. Brumfiel United States	8	63 0.3×	146 1.2×	57 0.6×	11 0.2×	34 0.9×	25	237
Barbara Vigone Italy	7	114 0.5×	44 0.4×	60 0.6×	31 0.5×	40 1.1×	11	229
Miriam Hakim United States	3	176 0.7×	166 1.4×	15 0.1×	35 0.6×	56 1.5×	3	321
Suhan Günaştı Türkiye	7	105 0.4×	48 0.4×	15 0.1×	53 0.9×	125 3.4×	13	285
Elisa Visalli Italy	7	103 0.4×	33 0.3×	54 0.5×	11 0.2×	60 1.6×	18	178

Countries citing papers authored by Deborah McCloskey

Since Specialization

Citations

This map shows the geographic impact of Deborah McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah McCloskey more than expected).

Fields of papers citing papers by Deborah McCloskey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah McCloskey. The network helps show where Deborah McCloskey may publish in the future.

Co-authorship network of co-authors of Deborah McCloskey

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah McCloskey. A scholar is included among the top collaborators of Deborah McCloskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah McCloskey. Deborah McCloskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mishra, Hridesh, Pankaj Kumar Mishra, Deborah McCloskey, et al.. (2022). Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2. BMC Medicine. 20(1). 32–32. 9 indexed citations

2.

Schiopu, Elena, Vivien Hsu, Ann Impens, et al.. (2009). Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud’s Phenomenon Secondary to Systemic Sclerosis. The Journal of Rheumatology. 36(10). 2264–2268. 66 indexed citations

3.

McCloskey, Deborah, et al.. (2006). Bosentan in pulmonary arterial hypertension secondary to scleroderma.. PubMed. 33(1). 61–8. 25 indexed citations

4.

Seibold, James R., Philip J. Clements, Daniel E. Fürst, et al.. (1998). Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.. PubMed. 25(2). 302–7. 36 indexed citations

5.

Seibold, James R. & Deborah McCloskey. (1997). Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Current Opinion in Rheumatology. 9(6). 571–575. 19 indexed citations

6.

Wigley, Fred, James R. Seibold, Robert A. Wise, Deborah McCloskey, & William P. Dole. (1992). Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.. PubMed. 19(9). 1407–14. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact